Conju Princess BB

Manufacturer: Conju Inc
Effective date: 2011-01-24
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:27:03

Label at a glance#

ProductConju Princess BB

Active ingredientTITANIUM DIOXIDE, ARBUTIN, ADENOSINE

Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient: titanium dioxide, arbutin, adenosine

INACTIVE INGREDIENT SECTION

Inactive ingredient: water, titanium dioxide,cyclopentasiloxzne, ethylhexyl methoxycinnamate,propylene glycol, cyclohexasiloxane, butylene glycol dicaprylate/dicaprate, cetyl/peg/ppe-10/1 dimethicone, dimethicone,hexyl laurate, arbutin, tale, PEG-10 dimethicone, panax ginseng root extract, sorbitan, olivate, magnesium sulfate, sorbitan sesquioleate, disteardimonium hectorite,quaternium-19bentonite, chamomilla recutita (matricaria) flower extract, silica, triethyl citrate, allantoin, tocopheryl acetate, dipotassium clycyrrhizate, iron oxide (CI 77492), iron oxide (CI 77491), iron oxide (CI 77499), ultramarines (CI 77007), triethoxycaprylylsilane, propylparaben, methylparaben, phenoxyethanol, adenosine, mica, sodim hyaluronate

OTC - PURPOSE SECTION

helps prevent sunburn

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

After following the daily skin care routine, apply the Conju Princess BB Cream generously onface and sensitive area. Reapply it again every two hours if sensitive exposure is contrast and also be used as a make-up base

WARNINGS SECTION

Warning
For external use only
When using this product
■ Avoid eye area. If contact occurs, rinse eyes thoroughly　with water
■ If following abnormal symptoms occurs after use, stop use and ask doctor
red specks, swelling, itching

DOSAGE & ADMINISTRATION SECTION

- for external use only

- apply frequently when needed

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ADENOSINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d676a241-be05-4740-b3ee-1a5f2ed422d2	Product name	4	20180615
dd8bd48f-20d6-43c7-b471-3ae872868afa	Product name	3	20180125
d41954ff-bc63-4b2c-aba0-9146707659d7	Product name	2	20151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59915-1001-1	2019-10-29	C162847	48780-1	960f7f55-c59f-8e05-e053-dbdaa90a074a	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59915-1001-1	Conju Princess BB	30 mL in 1 TUBE	CREAM	30		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59915-1001	CONJU PRINCESS BB (ARBUTIN) CREAM [CONJU INC]	1	Legacy NDC, 1 package rows	20110126_5c6d6598-37a3-4516-9170-fb976e11c1e7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ADENOSINE	ACTIVE INGREDIENT	K72T3FS567	1
ARBUTIN	ACTIVE INGREDIENT	C5INA23HXF	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	1
ADENOSINE	ACTIVE MOIETY	K72T3FS567	1
ARBUTIN	ACTIVE MOIETY	C5INA23HXF	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1
.ALPHA.-TOCOPHEROL ACETATE, DL-	INACTIVE INGREDIENT	WR1WPI7EW8	1
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	1
ASIAN GINSENG	INACTIVE INGREDIENT	CUQ3A77YXI	1
BENTONITE	INACTIVE INGREDIENT	A3N5ZCN45C	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
CHAMOMILE	INACTIVE INGREDIENT	FGL3685T2X	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	1
CYCLOMETHICONE 6	INACTIVE INGREDIENT	XHK3U310BA	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	1
HECTORITE	INACTIVE INGREDIENT	08X4KI73EZ	1
HEXYL LAURATE	INACTIVE INGREDIENT	4CG9F9W01Q	1
HYALURONATE SODIUM	INACTIVE INGREDIENT	YSE9PPT4TH	1
LICORICE	INACTIVE INGREDIENT	61ZBX54883	1
MAGNESIUM SULFATE, UNSPECIFIED	INACTIVE INGREDIENT	DE08037SAB	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	1
OCTINOXATE	INACTIVE INGREDIENT	4Y5P7MUD51	1
OCTYLTRIETHOXYSILANE	INACTIVE INGREDIENT	LDC331P08E	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SORBITAN OLIVATE	INACTIVE INGREDIENT	MDL271E3GR	1
SORBITAN SESQUIOLEATE	INACTIVE INGREDIENT	0W8RRI5W5A	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 34 matching rows.

Conju Princess BB
arbutin
TITANIUM DIOXIDE
ADENOSINE
WATER
CYCLOMETHICONE 5
OCTINOXATE
PROPYLENE GLYCOL
CYCLOMETHICONE 6
BUTYLENE GLYCOL
DIMETHICONE
HEXYL LAURATE
TALC
ASIAN GINSENG
SORBITAN OLIVATE
MAGNESIUM SULFATE, UNSPECIFIED
SORBITAN SESQUIOLEATE
HECTORITE
BENTONITE
CHAMOMILE
SILICON DIOXIDE
TRIETHYL CITRATE
ALLANTOIN
.ALPHA.-TOCOPHEROL ACETATE, DL-
LICORICE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE
OCTYLTRIETHOXYSILANE
PROPYLPARABEN
METHYLPARABEN
PHENOXYETHANOL
MICA
HYALURONATE SODIUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
59915-1001	59915-1001-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 33 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB
ARBUTIN	C5INA23HXF	ACTIB
ADENOSINE	K72T3FS567	ACTIB
WATER	059QF0KO0R	IACT
CYCLOMETHICONE 5	0THT5PCI0R	IACT
OCTINOXATE	4Y5P7MUD51	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
CYCLOMETHICONE 6	XHK3U310BA	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
DIMETHICONE	92RU3N3Y1O	IACT
HEXYL LAURATE	4CG9F9W01Q	IACT
TALC	7SEV7J4R1U	IACT
ASIAN GINSENG	CUQ3A77YXI	IACT
SORBITAN OLIVATE	MDL271E3GR	IACT
MAGNESIUM SULFATE, UNSPECIFIED	DE08037SAB	IACT
SORBITAN SESQUIOLEATE	0W8RRI5W5A	IACT
HECTORITE	08X4KI73EZ	IACT
BENTONITE	A3N5ZCN45C	IACT
CHAMOMILE	FGL3685T2X	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
TRIETHYL CITRATE	8Z96QXD6UM	IACT
ALLANTOIN	344S277G0Z	IACT
.ALPHA.-TOCOPHEROL ACETATE, DL-	WR1WPI7EW8	IACT
LICORICE	61ZBX54883	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
OCTYLTRIETHOXYSILANE	LDC331P08E	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
MICA	V8A1AW0880	IACT
HYALURONATE SODIUM	YSE9PPT4TH	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 420 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	OINTMENT / RECTAL		27 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
BENTONITE	BENTONITE	A3N5ZCN45C	SHAMPOO, SUSPENSION / TOPICAL	3.25 %w/v		Exact identifier — unii candidate 11 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INFILTRATION		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM, EXTENDED RELEASE / TRANSDERMAL	58.13 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	ELIXIR / ORAL		9306 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / ORAL	1000 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL, METERED / TOPICAL		1225 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RECTAL	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	AEROSOL, FOAM / VAGINAL	0.1 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	OINTMENT / TOPICAL		29 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, COATED / ORAL	320.75 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	LOTION / TOPICAL		140 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SHAMPOO / TOPICAL	8 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SPRAY / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL, FOAM / TOPICAL		1800 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	OINTMENT / TOPICAL	74.6 %w/w		Exact identifier — unii candidate 35 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENTONITE	BENTONITE	A3N5ZCN45C	SUSPENSION / ORAL	65 mg/5ml		Exact identifier — unii candidate 11 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAVENOUS	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION/ DROPS / TOPICAL	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, DELAYED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SPRAY / NASAL		5 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	INJECTION / INTRAVENOUS		16624 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET / ORAL	0.2 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INTRAMUSCULAR		6 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	PASTE, DENTIFRICE / DENTAL	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO, SUSPENSION / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	POWDER, FOR SOLUTION / ORAL		126 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	DROPS / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / INTRAVENOUS	5 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	FILM / BUCCAL		1 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, EXTENDED RELEASE / ORAL		300 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	AEROSOL, FOAM / TOPICAL	0.04 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
HYALURONATE SODIUM	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / ORAL		29008 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PARENTERAL		18 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION/ DROPS / OPHTHALMIC	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	CAPSULE, EXTENDED RELEASE / ORAL		129 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / SUBCUTANEOUS		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		19 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	OINTMENT / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, DELAYED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION/ DROPS / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	CAPSULE, COATED, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
BENTONITE	BENTONITE	A3N5ZCN45C	SYSTEM / TRANSDERMAL	9.86 mg		Exact identifier — unii candidate 11 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET / ORAL		64 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
TRIETHYL CITRATE	TRIETHYL CITRATE	8Z96QXD6UM	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LOTION / TOPICAL		351 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM, AUGMENTED / TOPICAL		2 mg	Exact identifier — unii candidate 68 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ebf42107-3f8a-4d91-91be-f346ce1961d0			5c6d6598-37a3-4516-9170-fb976e11c1e7	2011-01-24	Warnings	Exact identifier spl id: ebf42107-3f8a-4d91-91be-f346ce1961d0 spl set id: 5c6d6598-37a3-4516-9170-fb976e11c1e7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.